Back to search
Large B-Cell Lymphoma With IRF4 Rearrangement
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Large B-Cell Lymphoma With IRF4 Rearrangement trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Large B-Cell Lymphoma With IRF4 Rearrangement trials you may qualify forThe purpose of this study is to evaluate safety and tolerability and to determine the maximum tolerated dose (MTD) or maximum administered dose (MAD) and/or rec…
This phase II trial tests the effectiveness of golcadomide and rituximab as bridging treatment before chimeric antigen receptor (CAR) T-cell therapy in patients…
This phase II trial studies how well nivolumab with or without varlilumab works in treating patients with aggressive B-cell lymphomas that have come back (recur…
The purpose of this study is to determine the safety and tolerability of intravenous (IV) and subcutaneous (SC) administration of XmAb13676 and to determine the…